LivaNova : Regulation FD Disclosure - Form 8-K
Livn-20230322 UNITED STATES SECURITIES AND... | March 24, 2023
Source: marketscreener.com
Stay updated with breaking news from Statistical Analysis Committee. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Livn-20230322 UNITED STATES SECURITIES AND... | March 24, 2023
14.03.2022 - LivaNova PLC (Nasdaq: LIVN), a market-leading medical technology and innovation company, today announced the 250th unipolar depression patient has been implanted in the RECOVER clinical study, “A Prospective, Multi-center, Randomized Controlled ... Seite 1